Published in J Bone Miner Metab on July 01, 2014
MicroRNA-103a-3p controls proliferation and osteogenic differentiation of human adipose tissue-derived stromal cells. Exp Mol Med (2015) 0.77
Molecular Mechanisms of Obesity-Induced Osteoporosis and Muscle Atrophy. Front Physiol (2016) 0.76
Effects of switching weekly alendronate or risedronate to monthly minodronate in patients with rheumatoid arthritis: a 12-month prospective study. Osteoporos Int (2016) 0.76
Systemic IL-6 Effector Response in Mediating Systemic Bone Loss Following Inhalation of Organic Dust. J Interferon Cytokine Res (2016) 0.75
Long-Term Administration of High-Fat Diet Corrects Abnormal Bone Remodeling in the Tibiae of Interleukin-6-Deficient Mice. J Histochem Cytochem (2015) 0.75
Bioinformatics and Microarray Analysis of miRNAs in Aged Female Mice Model Implied New Molecular Mechanisms for Impaired Fracture Healing. Int J Mol Sci (2016) 0.75
IL-6 Contributes to the Defective Osteogenesis of Bone Marrow Stromal Cells from the Vertebral Body of the Glucocorticoid-Induced Osteoporotic Mouse. PLoS One (2016) 0.75
Effects of strength training on osteogenic differentiation and bone strength in aging female Wistar rats. Sci Rep (2017) 0.75
Multiple organ dysfunction and systemic inflammation after spinal cord injury: a complex relationship. J Neuroinflammation (2016) 0.75
Regulation of Stem Cell Properties of Müller Glia by JAK/STAT and MAPK Signaling in the Mammalian Retina. Stem Cells Int (2017) 0.75
Shp2 Plays a Critical Role in IL-6-Induced EMT in Breast Cancer Cells. Int J Mol Sci (2017) 0.75
Bruton tyrosine kinase (Btk) suppresses osteoblastic differentiation. J Bone Miner Metab (2014) 0.75
Impaired immune and acute-phase responses in interleukin-6-deficient mice. Nature (1994) 8.85
Growth retardation and increased apoptosis in mice with homozygous disruption of the Akt1 gene. Genes Dev (2001) 6.15
Increased bone formation in osteocalcin-deficient mice. Nature (1996) 4.91
Excessive production of interleukin 6/B cell stimulatory factor-2 in rheumatoid arthritis. Eur J Immunol (1988) 4.20
Interleukin-6 deficient mice are protected from bone loss caused by estrogen depletion. EMBO J (1994) 3.60
A central role for Stat3 in IL-6-induced regulation of growth and differentiation in M1 leukemia cells. EMBO J (1996) 3.40
Protein kinase B alpha/Akt1 regulates placental development and fetal growth. J Biol Chem (2003) 3.27
Interleukin-6 and soluble interleukin-6 receptors in the synovial fluids from rheumatoid arthritis patients are responsible for osteoclast-like cell formation. J Bone Miner Res (1996) 2.86
IL-6, RANKL, TNF-alpha/IL-1: interrelations in bone resorption pathophysiology. Cytokine Growth Factor Rev (2004) 2.72
Critical role of the extracellular signal-regulated kinase-MAPK pathway in osteoblast differentiation and skeletal development. J Cell Biol (2007) 2.44
Biologic sequelae of interleukin-6 induced PI3-K/Akt signaling in multiple myeloma. Oncogene (2001) 2.39
Interleukin 6 plays a key role in the development of antigen-induced arthritis. Proc Natl Acad Sci U S A (1998) 2.37
The paradigm of IL-6: from basic science to medicine. Arthritis Res (2002) 2.34
Differentiation and growth arrest signals are generated through the cytoplasmic region of gp130 that is essential for Stat3 activation. EMBO J (1996) 2.07
Serial estimation of interleukin 6 as a measure of systemic disease in rheumatoid arthritis. J Rheumatol (1992) 1.83
Etk/Bmx, a tyrosine kinase with a pleckstrin-homology domain, is an effector of phosphatidylinositol 3'-kinase and is involved in interleukin 6-induced neuroendocrine differentiation of prostate cancer cells. Proc Natl Acad Sci U S A (1998) 1.70
Gab1 acts as an adapter molecule linking the cytokine receptor gp130 to ERK mitogen-activated protein kinase. Mol Cell Biol (1998) 1.66
Akt1 in osteoblasts and osteoclasts controls bone remodeling. PLoS One (2007) 1.56
Defective gp130-mediated signal transducer and activator of transcription (STAT) signaling results in degenerative joint disease, gastrointestinal ulceration, and failure of uterine implantation. J Exp Med (2001) 1.55
Specific inhibitors of the protein tyrosine phosphatase Shp2 identified by high-throughput docking. Proc Natl Acad Sci U S A (2008) 1.54
Serum soluble interleukin 6 (IL-6) receptor and IL-6/soluble IL-6 receptor complex in systemic juvenile rheumatoid arthritis. J Clin Invest (1994) 1.53
Inhibition of IL-6 for the treatment of inflammatory diseases. Curr Opin Pharmacol (2004) 1.52
Interleukin-6 inhibits transforming growth factor-beta-induced apoptosis through the phosphatidylinositol 3-kinase/Akt and signal transducers and activators of transcription 3 pathways. J Biol Chem (1999) 1.37
Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J Bone Miner Res (2002) 1.37
The phosphatidylinositol 3-kinase/AKT kinase pathway in multiple myeloma plasma cells: roles in cytokine-dependent survival and proliferative responses. Cancer Res (2000) 1.37
Extracellular signal-regulated kinase 1 (ERK1) and ERK2 play essential roles in osteoblast differentiation and in supporting osteoclastogenesis. Mol Cell Biol (2009) 1.36
Callus mineralization and maturation are delayed during fracture healing in interleukin-6 knockout mice. Bone (2007) 1.34
The roles of interleukin-6 in the pathogenesis of rheumatoid arthritis. Arthritis (2011) 1.33
Impaired skeletal development in interleukin-6-transgenic mice: a model for the impact of chronic inflammation on the growing skeletal system. Arthritis Rheum (2006) 1.31
Rheumatoid arthritis synoviocyte survival is dependent on Stat3. J Immunol (2002) 1.24
The role of the interleukin-6 family of cytokines in inflammatory arthritis and bone turnover. Arthritis Rheum (2003) 1.21
The high mobility group transcription factor Sox8 is a negative regulator of osteoblast differentiation. J Cell Biol (2005) 1.19
Interleukin-6: An osteotropic factor influencing bone formation? Bone (2005) 1.17
Serum interleukin-6 levels and joint involvement in polyarticular and pauciarticular juvenile chronic arthritis. Clin Exp Rheumatol (1993) 1.16
Effects of interleukin-6 on the metabolism of connective tissue components in rheumatoid synovial fibroblasts. Arthritis Rheum (1992) 1.13
Selective signaling by Akt2 promotes bone morphogenetic protein 2-mediated osteoblast differentiation. Mol Cell Biol (2009) 1.12
Signal transduction through gp130 that is shared among the receptors for the interleukin 6 related cytokine subfamily. Stem Cells (1994) 1.11
Ras-MAPK signaling in osteogenic differentiation: friend or foe? J Bone Miner Res (2006) 1.08
Glycoprotein 130 regulates bone turnover and bone size by distinct downstream signaling pathways. J Clin Invest (2004) 1.07
Bone vascularization and trabecular bone formation are mediated by PKB alpha/Akt1 in a gene-dosage-dependent manner: in vivo and ex vivo MRI. Magn Reson Med (2010) 1.05
A critical role for interleukin-6 family-mediated Stat3 activation in osteoblast differentiation and bone formation. Bone (2006) 1.04
Interleukin-6 inhibits bone formation in vitro. Bone Miner (1993) 1.03
Molecular basis of the cell specificity of cytokine action. Biochim Biophys Acta (2002) 1.01
Proinflammatory cytokines tumor necrosis factor-alpha and IL-6, but not IL-1, down-regulate the osteocalcin gene promoter. J Immunol (1992) 0.97
Interleukin-6 activates phosphatidylinositol-3 kinase, which inhibits apoptosis in human prostate cancer cell lines. Prostate (2000) 0.96
Combination of interleukin-6 and soluble interleukin-6 receptors induces differentiation and activation of JAK-STAT and MAP kinase pathways in MG-63 human osteoblastic cells. J Bone Miner Res (1998) 0.96
c-Src and IL-6 inhibit osteoblast differentiation and integrate IGFBP5 signalling. Nat Commun (2012) 0.94
Interleukin-6-type cytokines stimulate mesenchymal progenitor differentiation toward the osteoblastic lineage. Proc Assoc Am Physicians (1999) 0.93
Role for interleukin-6 in structural joint damage and systemic bone loss in rheumatoid arthritis. Joint Bone Spine (2010) 0.93
In vitro differentiation profile of osteoblasts derived from patients with Saethre-Chotzen syndrome. Bone (2005) 0.93
Extracellular-signal regulated kinase signaling pathway mediates downregulation of type I procollagen gene expression by FGF-2, PDGF-BB, and okadaic acid in osteoblastic cells. J Cell Biochem (2000) 0.92
Selective signaling by Akt1 controls osteoblast differentiation and osteoblast-mediated osteoclast development. Mol Cell Biol (2011) 0.89
Role of mitogen-activated protein kinase in osteoblast differentiation. J Orthop Res (2010) 0.84
Akt1 regulates phosphorylation and osteogenic activity of Dlx3. Biochem Biophys Res Commun (2012) 0.80
Study of active controlled monotherapy used for rheumatoid arthritis, an IL-6 inhibitor (SAMURAI): evidence of clinical and radiographic benefit from an x ray reader-blinded randomised controlled trial of tocilizumab. Ann Rheum Dis (2007) 4.05
Treatment of rheumatoid arthritis with humanized anti-interleukin-6 receptor antibody: a multicenter, double-blind, placebo-controlled trial. Arthritis Rheum (2004) 3.92
Chronic polyarthritis caused by mammalian DNA that escapes from degradation in macrophages. Nature (2006) 2.82
C5 palsy after decompression surgery for cervical myelopathy: review of the literature. Spine (Phila Pa 1976) (2003) 2.26
Circulating bone marrow-derived osteoblast progenitor cells are recruited to the bone-forming site by the CXCR4/stromal cell-derived factor-1 pathway. Stem Cells (2007) 1.92
Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. Biochem Biophys Res Commun (2005) 1.80
Measurements of pelvic flexion angle using three-dimensional computed tomography. Clin Orthop Relat Res (2003) 1.79
Randomized Teriparatide [human parathyroid hormone (PTH) 1-34] Once-Weekly Efficacy Research (TOWER) trial for examining the reduction in new vertebral fractures in subjects with primary osteoporosis and high fracture risk. J Clin Endocrinol Metab (2012) 1.74
Prevention of the onset and progression of collagen-induced arthritis in rats by the potent p38 mitogen-activated protein kinase inhibitor FR167653. Arthritis Rheum (2003) 1.65
Bone-derived IGF mediates crosstalk between bone and breast cancer cells in bony metastases. Cancer Res (2012) 1.65
Bone morphogenetic proteins in bone stimulate osteoclasts and osteoblasts during bone development. J Bone Miner Res (2006) 1.56
Cytoplasmic p21(Cip1/WAF1) regulates neurite remodeling by inhibiting Rho-kinase activity. J Cell Biol (2002) 1.54
Simple foraminifera flourish at the ocean's deepest point. Science (2005) 1.54
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 2: Advantages of anterior decompression and fusion over laminoplasty. Spine (Phila Pa 1976) (2007) 1.54
Extraskeletal myxoid chondrosarcoma: a Multi-Institutional Study of 42 Cases in Japan. Cancer (2003) 1.53
Does alendronate prevent collapse in osteonecrosis of the femoral head? Clin Orthop Relat Res (2006) 1.53
A clinical comparative study of the direct anterior with mini-posterior approach: two consecutive series. J Arthroplasty (2008) 1.50
Surgical strategy for cervical myelopathy due to ossification of the posterior longitudinal ligament: Part 1: Clinical results and limitations of laminoplasty. Spine (Phila Pa 1976) (2007) 1.46
Novel hydroxyapatite ceramics with an interconnective porous structure exhibit superior osteoconduction in vivo. J Biomed Mater Res (2002) 1.45
Generation of hyaline cartilaginous tissue from mouse adult dermal fibroblast culture by defined factors. J Clin Invest (2011) 1.45
A case of hepatitis C-associated osteosclerosis in an elderly Japanese man. Endocr J (2006) 1.45
Verification of the Robin and Graham classification system of hip disease in cerebral palsy using three-dimensional computed tomography. Dev Med Child Neurol (2011) 1.42
The vascular network in the femoral head and neck after hip resurfacing. J Arthroplasty (2008) 1.42
Scapulohumeral rhythm: relationship between motion velocity and rhythm. Clin Orthop Relat Res (2002) 1.42
Angiotensin II accelerates osteoporosis by activating osteoclasts. FASEB J (2008) 1.42
Synovial sarcoma is a stem cell malignancy. Stem Cells (2010) 1.42
Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J Biol Chem (2006) 1.41
Interosseous membrane of the forearm: an anatomical study of ligament attachment locations. J Hand Surg Am (2009) 1.41
Differential activation of extracellular signal-regulated protein kinase in primary afferent neurons regulates brain-derived neurotrophic factor expression after peripheral inflammation and nerve injury. J Neurosci (2003) 1.40
Bone morphogenetic protein signals are required for cartilage formation and differently regulate joint development during skeletogenesis. J Bone Miner Res (2002) 1.39
Continuous inhibition of MAPK signaling promotes the early osteoblastic differentiation and mineralization of the extracellular matrix. J Bone Miner Res (2002) 1.37
Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes. J Bone Miner Metab (2007) 1.34
Bone marrow-derived osteoblast progenitor cells in circulating blood contribute to ectopic bone formation in mice. Biochem Biophys Res Commun (2007) 1.32
Mechanical stress-induced apoptosis of endplate chondrocytes in organ-cultured mouse intervertebral discs: an ex vivo study. Spine (Phila Pa 1976) (2003) 1.32
VCP (p97) regulates NFkappaB signaling pathway, which is important for metastasis of osteosarcoma cell line. Jpn J Cancer Res (2002) 1.31
Three-dimensional corrective osteotomy of malunited fractures of the upper extremity with use of a computer simulation system. J Bone Joint Surg Am (2008) 1.31
Differential and collaborative actions of Rad51 paralog proteins in cellular response to DNA damage. Nucleic Acids Res (2005) 1.30
Sox9 sustains chondrocyte survival and hypertrophy in part through Pik3ca-Akt pathways. Development (2011) 1.30
Blunt thyroid trauma with acute hemorrhage and respiratory distress. J Emerg Med (2007) 1.29
Long-term results of surgery for forearm deformities in patients with multiple cartilaginous exostoses. J Bone Joint Surg Am (2007) 1.27
Apoptosis induced by the sonomechanical effects of low intensity pulsed ultrasound in a human leukemia cell line. Cancer Lett (2005) 1.26
Expression of extracellular matrix metalloproteinase inducer and enhancement of the production of matrix metalloproteinases in rheumatoid arthritis. Arthritis Rheum (2002) 1.25
Leptin regulates chondrocyte differentiation and matrix maturation during endochondral ossification. Bone (2005) 1.24
Radiographic predictors for the development of myelopathy in patients with ossification of the posterior longitudinal ligament: a multicenter cohort study. Spine (Phila Pa 1976) (2008) 1.24
Methylcobalamin increases Erk1/2 and Akt activities through the methylation cycle and promotes nerve regeneration in a rat sciatic nerve injury model. Exp Neurol (2010) 1.23
Cadherin-11-mediated interactions with bone marrow stromal/osteoblastic cells support selective colonization of breast cancer cells in bone. Int J Oncol (2008) 1.20
Change in knee cartilage T2 in response to mechanical loading. J Magn Reson Imaging (2008) 1.20
Change in the length of the ulnocarpal ligaments during radiocarpal motion: possible impact on triangular fibrocartilage complex foveal tears. J Hand Surg Am (2008) 1.20
CARM1 regulates proliferation of PC12 cells by methylating HuD. Mol Cell Biol (2006) 1.19
The source of axial pain after cervical laminoplasty-C7 is more crucial than deep extensor muscles. Spine (Phila Pa 1976) (2007) 1.19
Smad6/Smurf1 overexpression in cartilage delays chondrocyte hypertrophy and causes dwarfism with osteopenia. J Cell Biol (2004) 1.19
Matrix extracellular phosphoglycoprotein (MEPE) is highly expressed in osteocytes in human bone. J Bone Miner Metab (2004) 1.18
Migration of EndoButton after anatomic double-bundle anterior cruciate ligament reconstruction. Arthroscopy (2011) 1.17
PKA phosphorylates the p75 receptor and regulates its localization to lipid rafts. EMBO J (2003) 1.17
Capillary vessel network integration by inserting a vascular pedicle enhances bone formation in tissue-engineered bone using interconnected porous hydroxyapatite ceramics. Tissue Eng (2004) 1.13
Parthenolide, a natural inhibitor of Nuclear Factor-kappaB, inhibits lung colonization of murine osteosarcoma cells. Clin Cancer Res (2007) 1.13
The role of bone morphogenetic proteins in endochondral bone formation. Cytokine Growth Factor Rev (2005) 1.12
Stimulation of cyclooxygenase-2 expression by bone-derived transforming growth factor-beta enhances bone metastases in breast cancer. Cancer Res (2006) 1.12
Eleven cases of cardiac metastases from soft-tissue sarcomas. Jpn J Clin Oncol (2011) 1.12
Kinematics of the upper cervical spine in rotation: in vivo three-dimensional analysis. Spine (Phila Pa 1976) (2004) 1.12
Unusual skeletal metastases from myxoid liposarcoma only detectable by MR imaging. Eur Radiol (2003) 1.11
Gender differences in 3D morphology and bony impingement of human hips. J Orthop Res (2010) 1.11
Cartilage repair using an in vitro generated scaffold-free tissue-engineered construct derived from porcine synovial mesenchymal stem cells. Biomaterials (2007) 1.11
Influence of component positions on dislocation: computed tomographic evaluations in a consecutive series of total hip arthroplasty. J Arthroplasty (2004) 1.11
FDG-PET imaging for chronic expanding hematoma in pelvis with massive bone destruction. Skeletal Radiol (2005) 1.11
Outcome of total en bloc spondylectomy for solitary metastasis of the thoracolumbar spine. J Spinal Disord Tech (2004) 1.10
Serum adiponectin concentrations correlate with severity of rheumatoid arthritis evaluated by extent of joint destruction. Clin Rheumatol (2008) 1.09
Orphan receptor tyrosine kinase ROR2 as a potential therapeutic target for osteosarcoma. Cancer Sci (2009) 1.09
Repair of meniscal lesions using a scaffold-free tissue-engineered construct derived from allogenic synovial MSCs in a miniature swine model. Biomaterials (2012) 1.09
Clinical implications of serum C-reactive protein levels in malignant fibrous histiocytoma. Int J Cancer (2002) 1.09
Ultrasound screening of periarticular soft tissue abnormality around metal-on-metal bearings. J Arthroplasty (2011) 1.09
Kinematics of the cervical spine in lateral bending: in vivo three-dimensional analysis. Spine (Phila Pa 1976) (2006) 1.09
A new biotechnology for articular cartilage repair: subchondral implantation of a composite of interconnected porous hydroxyapatite, synthetic polymer (PLA-PEG), and bone morphogenetic protein-2 (rhBMP-2). Osteoarthritis Cartilage (2005) 1.09
Prognostic implication of SYT-SSX fusion type in synovial sarcoma: a multi-institutional retrospective analysis in Japan. Oncol Rep (2008) 1.09
Clinical impact of c-Met expression and its gene amplification in hepatocellular carcinoma. Int J Clin Oncol (2012) 1.08
Recovery of walking speed and symmetrical movement of the pelvis and lower extremity joints after unilateral THA. J Biomech (2004) 1.08
IGF-I secreted by osteoblasts acts as a potent chemotactic factor for osteoblasts. Bone (2008) 1.07
Effects of rotation on measurement of lower limb alignment for knee osteotomy. J Orthop Res (2004) 1.07
Prediction of response to neoadjuvant chemotherapy for osteosarcoma by gene-expression profiles. Int J Oncol (2004) 1.07
Surgical outcome of drop foot caused by degenerative lumbar diseases. Spine (Phila Pa 1976) (2007) 1.06
Matrix extracellular phosphoglycoprotein is expressed in causative tumors of oncogenic osteomalacia. J Bone Miner Metab (2011) 1.06
Kinematics of the subaxial cervical spine in rotation in vivo three-dimensional analysis. Spine (Phila Pa 1976) (2004) 1.05
Bone morphogenetic protein-2 promotes the haptotactic migration of murine osteoblastic and osteosarcoma cells by enhancing incorporation of integrin beta1 into lipid rafts. Exp Cell Res (2006) 1.05
Progression and cessation of collapse in osteonecrosis of the femoral head. Clin Orthop Relat Res (2002) 1.05
Clinical Trials Express: fracture risk reduction with denosumab in Japanese postmenopausal women and men with osteoporosis: denosumab fracture intervention randomized placebo controlled trial (DIRECT). J Clin Endocrinol Metab (2014) 1.05
Three-dimensional clavicular and acromioclavicular rotations during arm abduction using vertically open MRI. J Orthop Res (2007) 1.04
Preservation of the nuchal ligament plays an important role in preventing unfavorable radiologic changes after laminoplasty. J Spinal Disord Tech (2008) 1.04